- Home
- XTNT vs SNAL Comparison
XTNT vs SNAL Comparison
Compare XTNT & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- SNAL
- Stock Information
- Founded
- XTNT N/A
- SNAL 2000
- Country
- XTNT United States
- SNAL United States
- Employees
- XTNT N/A
- SNAL N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- SNAL Computer Software: Prepackaged Software
- Sector
- XTNT Health Care
- SNAL Technology
- Exchange
- XTNT Nasdaq
- SNAL Nasdaq
- Market Cap
- XTNT 60.9M
- SNAL 51.0M
- IPO Year
- XTNT N/A
- SNAL 2022
- Fundamental
- Price
- XTNT $0.62
- SNAL $1.41
- Analyst Decision
- XTNT
- SNAL
- Analyst Count
- XTNT 0
- SNAL 0
- Target Price
- XTNT N/A
- SNAL N/A
- AVG Volume (30 Days)
- XTNT 96.0K
- SNAL 232.8K
- Earning Date
- XTNT 08-07-2025
- SNAL 08-12-2025
- Dividend Yield
- XTNT N/A
- SNAL N/A
- EPS Growth
- XTNT N/A
- SNAL N/A
- EPS
- XTNT N/A
- SNAL 0.04
- Revenue
- XTNT $122,298,000.00
- SNAL $90,462,190.00
- Revenue This Year
- XTNT $11.64
- SNAL $24.50
- Revenue Next Year
- XTNT $7.59
- SNAL $20.27
- P/E Ratio
- XTNT N/A
- SNAL $39.36
- Revenue Growth
- XTNT 20.81
- SNAL 46.95
- 52 Week Low
- XTNT $0.33
- SNAL $0.52
- 52 Week High
- XTNT $0.80
- SNAL $3.42
- Technical
- Relative Strength Index (RSI)
- XTNT 44.76
- SNAL 57.12
- Support Level
- XTNT $0.56
- SNAL $1.33
- Resistance Level
- XTNT $0.67
- SNAL $1.52
- Average True Range (ATR)
- XTNT 0.05
- SNAL 0.19
- MACD
- XTNT -0.01
- SNAL -0.02
- Stochastic Oscillator
- XTNT 21.14
- SNAL 25.29
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About SNAL Snail Inc.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.